Psychiatry has spent a century trying to treat what it could not see. Patient-derived neurons are about to change that. Depression touches a staggering portio...

Mental health diagnostics have been in crisis for some time now due to increasing patient loads, lack of definitive diagnostics and adverse societal impact. This...

Standard of care treatments for neurological disorders like Parkinson’s still rely on therapeutic principles established over 50 years ago,12 and these treatment...

Ninety per cent of drug candidates that enter clinical trials never reach patients. Developing a single new medicine now costs more than a billion dollars. Too o...

From Afterthought to Design Driver Over the past decade, biomarkers have moved from the margins of oncology clinical trials into their structural core. Where ...

Oncology remains one of the highest-attrition areas in drug development, with only a small minority of candidates entering clinical testing going on to reach app...